Cargando…
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor for cervical cancer. Given the substantial disease and death associated with HPV and cervical cancer, development of a prophylactic HPV vaccine is a public health priority. We evaluated the cost-effectiven...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873748/ https://www.ncbi.nlm.nih.gov/pubmed/12533280 http://dx.doi.org/10.3201/eid0901.020168 |